Oligonucleotide primers for human interleukin-6 (IL-6) that bracketed the entire coding region of the gene were used in reverse transcriptase-polymerase chain reaction (RT-PCR) studies to examine IL-6 expression in peripheral blood mononuclear cells (PBMC). In addition to the predicted 0.64-kb RT-PCR product, a second 0.45-kb product was observed. Cloning and dideoxy sequence analysis of this product revealed evidence for an alternatively spliced IL-6 transcript lacking exon II. Further RT-PCR analysis using forward primers ending at or one base before the exon I donor splice site again yielded both products. Additional primers were designed and successfully used to selectively distinguish the two forms of IL-6 transcript. Both transcripts were prominent in peripheral blood monocytes and lymphocytes, whereas only the 0.64-kb, full-length transcript was prominent in the IL-6-producing 5637 (human bladder carcinoma) NTERLEUKIN-6 (IL-6) is a multifunctional cytokine involved in immunoglobin secretion by mature B cells, activation of cytotoxic T cells, and other immunologic activities."3 IL-6 activates acute-phase proteins in the liver and has been shown to be elevated in rheumatoid arthritis and other autoimmune disease^.^.^ This cytokine has also been implicated in hematopoietic malignancies including multiple myeloma and certain T-cell lymphoma^,'^"^ in which it has been postulated to participate as an autocrine growth factor.' IL-6 is produced by a wide variety of cell types, many of which are directly stimulated by this cytokine,3,10"' suggesting that some mechanism of control exists for IL-6 that keeps producer cells such as B cells from indiscriminately being induced by IL-6. There is intense interest in both understanding the control mechanisms operative in IL-6 cellular interactions and in developing functional agonists and antagonists as possible therapeutic agents.
NTERLEUKIN-6 (IL-6) is a multifunctional cytokine involved in immunoglobin secretion by mature B cells, activation of cytotoxic T cells, and other immunologic activities."3 IL-6 activates acute-phase proteins in the liver and has been shown to be elevated in rheumatoid arthritis and other autoimmune disease^.^.^ This cytokine has also been implicated in hematopoietic malignancies including multiple myeloma and certain T-cell lymphoma^,'^"^ in which it has been postulated to participate as an autocrine growth factor.' IL-6 is produced by a wide variety of cell types, many of which are directly stimulated by this cytokine,3,10"' suggesting that some mechanism of control exists for IL-6 that keeps producer cells such as B cells from indiscriminately being induced by IL-6. There is intense interest in both understanding the control mechanisms operative in IL-6 cellular interactions and in developing functional agonists and antagonists as possible therapeutic agents.
During the course of reverse transcriptase-polymerase chain reaction (RT-PCR) analysis of cytokine induction in peripheral blood mononuclear cells (PBMC), monocytes, and lymphocytes,12 we found evidence for two IL-6 RT-PCR products.13 Here we report our findings regarding a novel IL-6 transcript that strongly suggests the existence of an alternatively spliced form of IL-6 with exon I1 deleted.
I MATERIALS AND METHODS
Reagents. Lipopolysaccharide (LPS; phenol extract from Salmonella typhosa) and concanavalin A (con A) were obtained from Sigma Chemical Corp (St Louis, MO), dissolved in RPMI 1640 at 10 mg/mL, and stored at -20°C before use. Reagents for cDNA synthesis were obtained from Bethesda Research Laboratories (BRL; Bethesda, MD) and Promega (Madison, WI). PCR reagents were obtained from Perkin Elmer-Cetus (Norwalk, CT), BRL, and Promega. F'CR synthesis was performed using a Gene Amp 9600 system from Perkin Elmer-Cetus. Oligonucleotide primers were synthesized on an Applied Biosystems (Foster City, CA) Model 391 automated DNA synthesizer, The original forward and reverse IL-6 primers (designated Or and R1; see Fig 3C) as well as ,&actin primers have been previously published by other investigators.I4
Cell isolation and culture. PBMC were isolated from heparinized whole blood by ficoll-hypaque density centrifugation as pre- [4559] [4560] [4561] [4562] [4563] [4564] [4565] [4566] [4567] cell line. Northern analysis revealed, in addition to the predominant 1.3-kb transcript, several minor transcripts at 1.9 to 4.8 kb that hybridized with the alternatively spliced cDNA probe but not with an exon II probe. Western analysis revealed IL-6 polypeptides of predicted size (26 to 29 kD) in culture medium from PBMC, while showing an immunoreactive band a t 17 kD in cell lysates. These findings suggest the existence of an alternatively spliced form of IL-6 mRNA, which would encode for a polypeptide missing the gp130 interactive (signal-transducing) domain contained in exon II while retaining the IL-6 receptor (p801 domain. Such a molecule could in theory function as a natural antagonist of IL-6, as it would be expected to bind to the IL-6 receptor but not lead to signal transduction. 0 1995 by The American Society of Hematology.
viously described." Washed cells were cultured in RPMI 1640 medium supplemented with 50 U/mL penicillin, 50 pg/mL streptomycin, 10% fetal bovine serum, and 2 mmol/L L-glutamine (F10 medium) at 37°C in 5% C02/95% air. Monocytes were isolated from the PBMC by 4-hour adherence to polystyrene Petri dishes." Nonadherent cells (lymphocytes) were removed, the plates were washed repeatedly in F10 medium, and adherent cells (monocytes) were then released with calcium-deficient phosphate-buffered saline (PBS; pH 7.2) containing 2 mmol/L EGTA. Monocytes (greater than 90% pure by Giemsa staining) were collected by centrifugation (600g for 10 minutes), washed, and cultured in F10 medium in 24-well (16-mm diameter) tissue culture plates (Costar, Cambridge, MA) at 106/mL per well. Lymphocytes were reabsorbed on fresh Petri dishes to remove residual monocytes, then collected by centrifugation, washed, and cultured at 2 X 10' cells/mL per well in F10 medium. Monocytes and lymphocytes were cultured for 15 hours in the presence or absence of 1 pg/mL or 10 pg/mL con A or LPS as described in figure legends. The 5637 human bladder carcinoma cell line was obtained from the American Type Culture Collection (ATCC; Rockville, MD) and grown in F10 rnedium.l6 RNA isolation. RNA was extracted from cells using the guanidine isothiocyanate method," with all solutions made in diethylpyrocarbonate-treated water (DEPC-water). The extracted RNA was dissolved in 50 pL 0.25 mol/L Na-acetate (pH 6.0), precipitated with 2.5 volumes of absolute ethanol at -8O"C, washed several times with cold 80% ethanol, dried at room temperature, and dissolved in 1 mmol/L dithiothreitol (DIT) with 1 U/pL placental RNAse inhibitor (Promega).
RT-PCR analysis. Pur$cation of 115-bfragmerrts. Ethidium-stained RT-PCR fragments were excised from gels under ultraviolet light, electroeluted into sterile TEA buffer using autoclaved dialysis membrane:' adjusted to 200 mmol/L NaC1, and precipitated at -80°C with 2.5 volumes of absolute ethanol. After centrifugation (12,000g, 15 minutes), the precipitated DNA fragments were washed with 80% cold ethanol and vacuum-dried.
Southern analysis of IL-6 fragments. Southern analysis was performed according to established methods.2',2' In brief, agarose gels were denatured in 0.2 N NaOH, 1.5 molL NaCl for 45 minutes and then neutralized in 500 mmol/L Tris-HC1 (pH 7.2), 1.5 mol/L NaCl for 1 hour. Gels were blotted onto Biotrans (ICN, Irvine, CA) nylon membranes in 6X saline sodium citrate (SSC; 900 mmol/L NaCI, 90 mmol/L Na citrate, pH 7.0) for 16 hours, and the membranes were rinsed in 4X SSC and baked at 80°C under vacuum for 2 hours. Hybridization was performed at 65°C in 6X SSC containing 5X Denhardt's solution, 100 pg/mL sonicated hemng sperm DNA, 0.1 % sodium pyrophosphate, and IO6 cpm/mL "P-labeled, heat-denatured IL-6 cDNA probe. Probes were derived from the cDNA clone pT7.7/ h~1L-6~' obtained from ATCC and were labeled using random primer methods in the presence of 32P-deoxyadenosine triphosphate (dATP) and '*P-deoxycytidine triphosphate (dCTP, specific activity, 3,000 Ci/mmol/L; ICN) to a final specific activity of greater than I X 10' cpm/pg DNA.*"." After hybridization, the membranes were washed to a stringency of 0.1 x SSC at 65°C and exposed to X-omat film (Eastman Kodak, Rochester, NY) with Lightning Plus intensifying screens (Dupont, Wilmington, DE) at -80°C.
IL-6 fragment cloning and sequencing. The electroeluted IL-6 RT-PCR fragments were cloned using the TA vector system (Invitrogen, San Diego, CA). Plasmid DNA was extracted by alkaline lysis and further purified by precipitation with polyethylene glyc01.~"~~' Plasmid clones were analyzed by dideoxy chain termination sequencing using alkaline-denatured plasmid templates and United States Biochemical Corporation (Cleveland, OH) T7 polymerase sequencing protocols and reagents (Sequenase). The sequencing reactions were analyzed on 6.5% polyacrylamide gels containing urea, which were then dried and developed using X-omat or BMR (Eastman Kodak) film.
Northern analysis. Procedures were performed according to established methods." Briefly, RNA samples (7.5 pg) i n 30 pL 20 mmollL MOPS ([3'-(N-morpholino)-propanesulfonic acid], pH 8.01, 1 mmollL EDTA, 50% formamide, and 0.40/r xylene cyanole/bromophenol blue were heated at 55°C for 15 minutes and then cooled rapidly on ice. RNA samples were electrophoresed on 1.2% agarose gels in 20 mmollL MOPS (pH 8.0), I mmol/L EDTA, 1.1% formaldehyde. Lanes containing an RNA ladder (GIBCO-BRL) and ribosomal RNA for size reference were stained with ethidium bromide ( O S pgImL) and photographed with a ruler under ultraviolet (UV) transillumination. Gel portions to be transferred were washed twice (30 minutes each) in DEPCwater, once in 1OX SSC, and then transferred (16 hours, room temperature) by imbibition onto Biotrans nylon membranes using a wick and 1OX SSC. The blots were rinsed in 4 x SSC, baked at 80°C for 90 minutes under vacuum, and prehybridized (41°C. 6 hours) in IOX SSC, 5 X Denhardt's solution, 40% formamide, 0.5% sodium dodecyl sulfate (SDS), 0. I % sodium pyrophosphate, 150 pg/mL denatured herring sperm DNA. Hybridization was performed at 41°C for 16 hours with '*P heat-denatured cDNA probe ( 1 Oh cpm/mL; specific activity, greater than I Ox cpm/pg DNA) in prehybridization buffer containing 10% dextran sulfate, followed by washing twice (15 min, room temperature) in 3X SSC and then further washing to a final stringency of 0. I X SSC at 55°C. The membranes were then exposed to X-ray film with intensifying screens at -80°C and developed.
The alternatively spliced cDNA probe (clone Ss-l insert excised with EcoRI) was generated by a-'*P-dCTP and "P-dATP random primer labeling of gel-purified fragment to a specific activity of greater than 10' cpmlpg. IL-6 exon I1 specific fragment was generated by two 25-cycle PCR amplifications of a pT7.7huIL-6 fragment generated by Bgl 11-BamHI digestion and electrophoretic purification. The fragment was amplified as described above using the following primers, which span 123 nucleotides of exon I1 (nucleotides 88 to 21 1 from the ATG start codon): forward primer: S'GTA/CCC/ CCA/GGA/GAA/GAT/TCC (21 mer); reverse primer: S'CTC/CT/ TCT/CAG/GGC/TGA/GAT (21 mer). The resultant exon I1 PCR product was purified by gel electrophoresis and labeled to greater than 10' cpm/pg using random primer methods as described."'.*' Before Northern blot experiments, the probes were shown to be specific by hybridization to blotted PCR-amplified exon I1 or exon 111.
Western blors. PBMC were cultured at 2 X IOh/mL for 16 hours in serum free Hybridoma Medium S2897 (Sigma) with or without 10 pg/mL LPS. Aliquots of conditioned media (CM; 4 mL) were concentrated and electrophoresed on SDS-I 1% polyacrylamide gel electrophoresis (PAGE) Laemmli gels and analyzed on Western blots as described.?" Gels were transblotted onto 0.2-pm nitrocellulose filters for 4 hours at 150 mA in 25 mmol/ L Tris (pH 8.0), 200 mmollL glycine, 20% (wt/vol) methanol, and 0.1% SDS, and the filters were then blocked for 90 minutes in PBS containing 7.5% non-fat dry milk at 37°C. Filters were washed twice for 5 minutes in PBS and then incubated for 90 minutes at room temperature with 10 mL of either 1/500 rabbit anti-IL-6 antiserum (Sigma) or normal rabbit serum diluted in PBS containing 4% normal goat serum. The filters were washed twice (10 minutes each) in 20 mL PBS, 0.01% Tween 20 and once in PBS and then incubated with 1/5,000 alkaline phosphataseconjugated goat anti-rabbit IgG (Promega) in PBS containing 4% normal goat serum. Filters were then washed twice (15 minutes each) with 25 mL PBS-Tween and once with PBS and then developed using the Protoblot AP System (Promega) with BCIP (5-bromo-4-chloro-3-indolyl phosphate) and nitroblue tetrazolium in 100 mmollL Tris-HCI (pH 9 . 9 , 100 mmol/L NaCI. S mmollL MgCI2, according to the manufacturer's instructions. 
RESULTS
In studies designed to examine IL-6 transcript levels in PBMC, we initially used primers bracketing the entire IL-6 coding region. A forward 21-mer primer (Or for original) beginning at the ATG initiation codon and a reverse 3 l-mer primer ( R I ) were chosen that extended three bases beyond the open reading frame through the stop codon (see Fig 3C  for primer sequences) .""" Unstimulated PBMC as well as purified lymphocytes and monocytes from most donors revealed little or no detectable IL-6 RT-PCR product. In LPSstimulated PBMC, monocytes. and lymphocytes, an RT-PCR product of 0.64 kb was observed, which was consistent with the predicted size. In addition to the expected IL-6 RT-PCR product, a second product of 0.45 kbp was consistently observed in these cells (Fig 1) . In contrast, the human bladder carcinoma cell line 5637, which is known to constitutively produce IL-6 as well as a number of other cytokines,'h.'3 showed a prominent 0.64-kbp RT-PCR product but significantly less 0.45-kbp product.
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IL-6-primed RT-PCR products from 15-hour LPS-stimulated monocytes were further analyzed by Southern hybridization using a "P-labeled full-length IL-6 cDNA probe (pT7.7/huIL-6)." Figure 2 shows that both the predicted 0.64-kbp and the smaller 0.45-kbp IL-6 RT-PCR products hybridized appreciably with the "P-labeled IL-6 cDNA. The salt and temperature conditions of the washes were stringent (0.1 X SSC, 6X°C), which supports high homology between the 0.45-kbp RTPCR product and IL-6.
Therefore, we isolated and cloned the 0.45-kbp fragment from this RT-PCR mixture. Dideoxy sequence analysis of this clone (clone Or-l; Fig 3B and C) revealed that it was identical to the IL-6 coding region, with all of exon I1 deleted except for the first G (nucleotide 20). We hypothesized that the 0.45-kbp fragment represented the product of an alternatively spliced IL-6 transcript with exon I1 spliced out, and that the G at nucleotide 20 in clone Or-l was the result of PCR amplification using forward primer Or, which extends two bases past the exon I donor splice site into exon 11. To test this hypothesis, we designed a forward primer (Ss; Fig  3C) 
19, A).
Using the Ss forward primer and the RI reverse from clone Ss-l, but in contrast to clone Or-l, clone Ss-l primer, we again generated the 0.64-and 0.45-kbp IL-6 RT-remained in frame between exons I and 111. A proposed PCR fragments previously observed. We subsequently isomodel of this alternatively spliced isoform of IL-6 is dialated, cloned, and dideoxy sequenced this Ss-primed, 0.45-grammed in Fig 4. In clone Ss-l, in which exon I1 is deleted, kbp fragment (clone Ss-l). Sequence analysis of this clone 6.3 codons are provided by exon I and 37.7 codons are (Fig 3A and C) 
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The splice site primer Ss (Fig 3C) and a second forward primer (PS, for presplice) that terminated one base before the exon I splice donor site at nucleotide 18 (A) were used with the reverse primer R1 in further RT-PCR studies using RNA from LPS-stimulated lymphocytes. As seen in Fig S  (lanes 1 and 2) , each of these primers generated both the full and alternative forms of IL-6.
To specifically amplify either the full-length or alternative form of IL-6 transcript, we synthesized additional IL-6 forward primers. The specific full-size primer (designated Fs; see Fig 3C) was a 24-mer primer that ended five bases into exon I1 from the exon I splice/donor site at nucleotide 19 (A). The specific alternatively spliced forward IL-6 primer (designated As; see Fig 3C) was also a 24-mer primer that ended five bases beyond the exon I splice-donor site, except it extended into exon 111. As shown in Figs SA and 6A, these primers showed specificity for full-size and alternatively spliced IL-6 transcripts using RNA from stimulated monocytes or lymphocytes. By comparison, the original forward primer (Or), the splice site primer (Ss), or the presplice junction primer (PS) resulted in amplification of both RT-PCR products.
We also observed differential expression of the alternative IL-6 transcript in RNA from LPS (B-cell mitogen)-stimulated and con A (T-cell mitogen)-stimulated lymphocytes, as shown in Fig 6A (compare lanes 4 through 6 and 7 through  9) . These findings were confirmed by Southern analysis of the RT-PCR products (Fig 6B) . &actin primed RT-PCR products from stimulated and unstimulated lymphocytes were similar in intensity, suggesting that the differential expression of the IL-6 isoforms was not due to differences in the amount or integrity of RNA between samples.
A number of laboratories have reported a predominant 1.2 to 1.4-kb transcript observed on Northern blots probed with For Agarose gel analysis of RT-PCR products from unstimulated, con A-stimulated, and LPS-stimulated lymphocytes using isoform-specific 11-6 forward primers. (A) Ethidium-stained gel of RT-PCR products from lymphocytes cultured for 15 hours in medium alone (lanes 1 through 3,10) ,10 pg/mL LPS (lanes 4 through 6,111. or 10 pg/mL con A (lanes 7 through 9, 12). Forward primers used were as follows: Or (lanes 1, 4, 7) ; Fs (lanes 2, 5, 8); As (lanes 3, 6, 9); p-actin (lanes 10 through 12). R1 (IL-6) reverse primer was used in lanes 1 through 9 and p-actin in lanes 10 through 12. p-actin RT-PCR products served as control for RNA amounts and integrity be- IL-6 cDNA,"." but there is evidence for additional IL-6 transcripts and multiple transcriptional start Other laboratories have reported that alternatively spliced mRNAs are frequently a minor species and difficult to We, therefore, performed Northern blot experiments on LPSstimulated PBMC RNA using prolonged autoradiography to increase detection of minor mRNAs, after probing with either "P-labeled. alternatively spliced cDNA (Ss-l) or an exon I1 probe generated by double-PCR amplification using exon 11-specific primers. As shown in Fig 7, in addition to the predominant 1.3-kb band, several RNA species were observed in the 1.9-kb ( 1 8s) to 4.8-kb (28s) region that were LPS-inducible and hybridized with the alternatively spliced cDNA probe (lacking exon 11) but not with the exon IIspecific probe. Whether one or more of these bands corresponds to alternatively spliced mRNA will require additional studies. It is of interest that studies by others have shown that alternatively spliced mRNAs may be larger than the full-length transcript, possibly due to differences in the 3' untranslated region or other factors:"."
Finally, we performed Western blot studies testing for the KESTLER ET AL presence of a putative protein representing the alternatively spliced mRNA (Fig 8) . Consistent with studies from other laboratories, in conditioned medium from LPS-stimulated PBMC, we detected two protein bands at 26 to 29 kD, which are believed to represent variably glycosylated. secreted IL-6 molecules that are larger than the unmodified 21 .S-kD mature 1L-6.33," In detergent-lysed cells, we observed a major protein band at 35 kD that may represent aggregated IL-6. A second LPS-inducible protein band was observed at 17 kD, which is consistent with the size of a protein translated from an alternatively spliced mRNA lacking exon 11, as our studies support. Interestingly, in human fibroblasts, an IL-6 polypeptide of 17 to 19 kD, attributed to posttranslational modification, has been reported by others.''
DISCUSSION
The relationship between structure and function of the 1L-6 molecule is currently under intense scrutiny in many laboratories.15-" The IL-6 gene is known to contain a 636-bp coding region encoding 212 amino acids in five exons (see Fig 4) .'.-' Initial mutational studies of the IL-6 coding region suggested that two essential regions for biologic activity of IL-6 are localized to exon 11, codons 29 (ile) to 34 (leu), and exon V, codons 181 (ala) to 185 (met) and IS4 (ala) to 163 (thr).'.'.35.3'1 These and other data support a structural model similar to those for granulocyte colony-stimulat- Northern analysis of PBMC RNA using IL-6-specific cDNA probes. Total RNA (7.5 p g l derived from PBMC cultured for 16 hours was subjected t o Northern analysis using either an IL-6 exon Il-specific cDNA probe (lanes 1 through 3) or an alternatively spliced IL-6 probe (insert from clone Ss-l) lacking exon II (lanes 4 through 6). For personal use only. on October 27, 2017. by guest www.bloodjournal.org From do not hybridize with an exon I1 cDNA probe, suggesting that one or more may represent the alternatively spliced transcript lacking exon I1 that our RT-PCR studies support. However, further studies will be needed to substantiate this. In addition. Western blot studies presented in this report have detected a 17-kD anti-1L-6 polypeptide in SDS lysates of PBMC stimulated with LPS. which would be consistent with the size of an alternatively spliced isoform of IL-6 lacking exon 11. Again, additional studies ideally including protein sequencing will be necessary to support this hypothesis.
Our studies have identified by RT-PCR an alternative form of IL-6 transcript that is missing exon 11, and the data suggest that this form arises by alternative splicing of IL-6 precursor mRNA. The predicted polypeptide would be missing the majority of helix A, which contains the gp130 interactive domain of IL-6 (site 2). Theoretically, this alternative form of IL-6 could bind to IL-6R (p80), but would be unable to interact with gp130 and, thus, would be deficient in signal transduction or high affinity binding-site forrnati~n.~'," Thus, such an alternative form of IL-6 could function as a natural antagonist of IL-6.
An analogous situation has been observed with hepatocyte growth factor, in which an alternatively spliced smaller transcript results in a molecule lacking the mitogenic activity while retaining the ability to bind to the c-met (protooncogene) hepatocyte growth factor receptor?' Human growth For personal use only. on October 27, 2017. by guest www.bloodjournal.org From hormone, which also has a four-helix structure similar to the 1L-6 family of cytokines, has several alternative forms. one of which possesses human growth hormone activity but lacks its normal insulin-like growth factor a~tivity.~' In the IL-6 family of cytokines, ciliary neurotropic factor and LIF have both been reported to exhibit alternatively spliced f~rrns.~',~'
Our findings further suggest that this alternative form of IL-6 is preferentially expressed in LPS-stimulated lymphocytes and monocytes but is reduced or absent in con Astimulated lymphocytes and the human bladder carcinoma cell line 5637, suggesting an important role in B cells and perhaps monocytes. Further studies designed to identify and characterize this IL-6 isoform are in progress.
